Pulmonx logo

Pulmonx

LUNG | NASDAQ
Chart Builder DCF Calculator
$2.80
-$0.06 (-2.10%)
At close: Nov 16, 2026, 4:00 PM ET
$2.80
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:15 PM ET
-2.10%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
42.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #459/1021 (Top 45%)

Key Statistics

Market Data

Market Cap $121.94M
1D Range
2.69 2.90
52W Range
1.17 3.17

Valuation (TTM)

PE -2.80
PB 3.57
EV/EBITDA -3.41

Valuation (NTM)

Forward PE N/A
Forward PEG 0.08
Price Target $5.00
Loading financial charts...

Profile

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offerin...

Sector Healthcare
Employees 296
IPO Date Oct 1, 2020
Website pulmonx.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 27, 2026
EPS
-$0.19
Beat +25.96%
REV
$22.84M
Beat +4.11%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+78.57%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.